Name | 2-[[3-(2-amino-2-carboxyethyl)-2,6-dioxo-1-pyrimidinyl]methyl]benzoic acid |
---|---|
Synonyms |
2-{[3-(2-Amino-2-carboxyethyl)-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl]methyl}benzoic acid
1(2H)-Pyrimidinepropanoic acid, α-amino-3-[(2-carboxyphenyl)methyl]-3,4-dihydro-2,4-dioxo- 2-[[3-(2-amino-2-carboxyethyl)-2,6-dioxo-1-pyrimidinyl]methyl]benzoic acid 2-{[3-(2-Amino-2-carboxyethyl)-2,6-dioxo-3,6-dihydro-1(2H)-pyrimidinyl]methyl}benzoic acid |
Description | UBP296 is a potent and selective antagonist of GLUK5-containing kainate receptor in the spinal cord. UBP296 reversibly blocks ATPA-induced depressions of synaptic transmission, and affects AMPA receptor-mediated synaptic transmission directly in rat hippocampal slices[1]. |
---|---|
Related Catalog | |
Target |
IC50: 3.5 ± 1.5 μM (GLUK5), 4.0 ± 0.7 μM (GLUK5/GLUK6), 7.0 ± 5.1 μM (GLUK5/GLUK2)[1] |
References |
Density | 1.5±0.1 g/cm3 |
---|---|
Boiling Point | 603.0±65.0 °C at 760 mmHg |
Molecular Formula | C15H15N3O6 |
Molecular Weight | 333.30 |
Flash Point | 318.5±34.3 °C |
Exact Mass | 333.096100 |
LogP | 1.58 |
Vapour Pressure | 0.0±1.8 mmHg at 25°C |
Index of Refraction | 1.659 |